To gain insight into the cellular regulation of bovine leukemia virus (BLV) trans activation, a lambda-gtll cDNA library was constructed with mRNA isolated from a BLV-induced tumor and the recombinant proteins were screened with an oligonucleotide corresponding to the tax activation-responsive element (TAR) 
Bovine leukemia virus (BLV) is the causative agent of enzootic bovine leukosis, a lymphoproliferative disease of cattle (4) . The 3' end of the BLV provirus encodes a protein called tax involved in trans activation of long terminal repeat (LTR)-directed gene expression (5, 24) . Furthermore, tax is able to transform primary cells in cooperation with the ras oncogene and can thus be considered as a member of the immortalizing oncogene subgroup (25) .
trans activation of the BLV LTR by p34tax requires a 75-bp element present in the U3 region (5) . Nucleotide sequence data show that this cis-acting element is composed of two 21-bp repeats centered around 148 and 123 bp upstream of the RNA start site. A third related element found at position -48 upstream of the RNA cap site is apparently poorly active in the absence of upstream sequences. These three repeats are very similar with respect to their nucleotide sequence and spatial array to elements found in the LTRs of human T-cell lymphotropic virus types I (HTLV-I) and -II. All these elements have a common 8-bp core sequence, TGACGTCA, known as the cyclic AMP (cAMP)-responsive element (CRE) or the binding site of a cellular transcription factor, ATF (15) . The mutually exclusive trans activation of the BLV and HTLV promoters by their cognate tax proteins would suggest that the shared CRE represents a functional center of a larger response element whose specificity is determined by the flanking nucleotides.
In the HTLV system, the 21-bp repeat elements are essential for basal expression and trans activation by taxI. Since taxI does not directly bind to the 21-bp element, it may * Corresponding author. exert its effect through the cellular proteins that recognize these sequences. Several different proteins binding to the HTLV LTR have been identified (1, 7, 14, 17, 18) . Four cDNA clones encoding nuclear proteins that bind to the 21-bp element were recently isolated from an HTLV-Iinfected cell line (21, 28) . All these proteins contain a leucine zipper and a basic amino acid domain (which are conserved in Fos, Jun, and CREB) and multiple potential phosphorylation sites.
The HTLV-I LTR-directed expression is modulated through the protein kinase A (PKA) and protein kinase C (PKC) pathways. The taxI-responsive element (TAR) is different from the sequences required for cAMP and 12-0-tetradecanoylphorbol-13-acetate (TPA) activation (6) . Furthermore, the cAMP and TPA activators can enhance HTLV-I LTR-directed gene expression in the absence of the taxI transactivator. In contrast, the BLV LTR does not (or very poorly) respond to activation by cAMP and TPA in experimental conditions known to enhance expression in the HTLV-I system (unpublished data). Moreover, the BLV LTR is silent in the absence of the tax protein (5, 24) . The apparent lack of basal expression of the BLV LTR and the observed lack of responsiveness to soluble cAMP analogs and TPA thus seem correlated.
These two main differences between BLV and HTLV-I prompted us to study cellular factors binding to the BLV 21-bp element. We isolated and characterized a TAR-binding protein (TBP) which appeared to be the bovine CREB2 protein. We also demonstrated that CREB2 trans activates the BLV LTR and does so significantly when a PKAexpressing plasmid is cotransfected with the CREB2-expressing construct.
MATERIALS AND METHODS
Construction of lambda-gtll cDNA library. RNA was prepared from a BLV-induced tumor from bovine 3894. cDNAs were prepared by using oligo(dT)12-18 as primers.
The cDNAs were cloned at the unique EcoRI site of lambdagtll vector by the method of Huynh et al. (13) . Recombinant lambda bacteriophages from an amplified library were used to infect the Y1090 strain of Escherichia coli and induced to produce ,B-galactosidase fusion proteins as described by Huynh et al. (13) .
Screening of protein replica ifiters with DNA binding site probes (20) . Protein replica filters were prepared by the method of Huynh et al. (13) (11) .
Preparation of nuclear extracts. Nuclear extracts were prepared from FLK cells (BLV-infected fetal lamb kidney) as described previously (16 
RESULTS
Isolation of cDNA encoding a TBP. To gain insight into the regulation of BLV expression, we decided to identify and characterize cellular proteins involved in the trans activation complex. The 21-bp TAR element appears to be a major determinant in LTR responsiveness to the p34tax transactivator protein. Therefore, a lambda-gtll cDNA expression library was prepared from mRNA extracted from a bovine tumor (T3894), and the recombinant proteins were screened with a 32P-labeled oligonucleotide corresponding to the TAR sequence (20) . Two clones (called lambda-TBP1 and -2) from 750,000 phage plaques were identified and purified. Southern hybridization and restriction map analysis showed that the two cDNAs corresponded to the same transcript (data not shown).
The specificity of the DNA-binding activity of the protein expressed by one of the cDNAs (lambda-TBP1) was confirmed by Southwestern (DNA-protein) and gel shift assays. Y1089 lysogens were obtained after infection with recombinant lambda-TBP1, and a lysate was analyzed by Western blotting (immunoblotting) with a rabbit anti-,-galactosidase serum. A fusion protein of approximately 150 kDa was observed (Fig. 1A , anti-BGAL, lane A). Lanes B and C correspond to control lysates containing P-galactosidaseTax (138 kDa) or 0-galactosidase (114 kDa) protein, respectively (23) . Only the ,-galactosidase-Tax product was revealed by a mixture of monoclonal antibodies directed against tax (25) (Fig. 1A, anti-TAX, lane B) .
Southwestern experiments demonstrated that the 21-bp oligonucleotide AAGCTGGTGACGTCAGCTGGT These Southwestern experiments were confirmed by DNA gel shift assays with the two oligonucleotides mentioned above and partly purified Y1089 lysates (Fig. 1C) . It appeared that efficient binding between the TBP and the 32P-end-labeled TAR oligonucleotide indeed requires the CRE.
Nucleotide sequence of lambda-TBP1 cDNA. After subcloning into plasmid pGem7Zf, the lambda-TBP1 EcoRI insert was completely sequenced (26) . This analysis revealed that the 1,093-bp fragment corresponds to the bovine homolog of the CREB2 cDNA. The amino acid sequence revealed that TBP contains a leucine zipper structure (residues 297 to 319), a basic amino acid domain (residues 271 to 294), and several potential phosphorylation sites. Seven point mutations in 315 amino acids were identified at the amino terminus in comparison with the human sequence (12, 26) . None of them affected the above-mentioned domains.
It is important to mention here that the bovine CREB2 differs from the proteins recently identified in the HTLV-I system (21, 28) . However, all these TBPs are structurally related and belong to the CREB/ATF family.
CREB-like nuclear factor binds to TAR(CRE) sequence. As a control, cRNA to the CREB2 cDNA was synthesized by using SP6 RNA polymerase and translated in a rabbit reticulocyte lysate. 32P-labeled TAR(CRE) oligonucleotides of 21 bp were incubated with the in vitro-synthesized CREB2 proteins. After binding, the DNA-protein complexes were separated on a nondenaturing gel. Several complexes were observed (Fig. 2, lane 1) . They were blocked by a TAR(CRE) unlabeled probe (Fig. 2, lane 3) but not by the TAR(TRE) oligonucleotide (Fig. 2, lane 2) .
When a nuclear extract prepared from BLV-infected FLK cells was incubated with a 32P-labeled TAR(CRE) probe, a specific complex was observed (Fig. 2, lane 4) . This complex was blocked when the unlabeled TAR(CRE) sequence was To gain insight into a possible involvement of the cAMP pathway in this process, we introduced the 1,093-bp EcoRI insert of the bovine CREB2 cDNA into a eukaryotic expression vector (pSGCREB) and transfected it into D17 osteosarcoma cells, in which high activation by tax has been demonstrated (5) ( Table 1) . As an internal transfection control, we used the pRSVPGal plasmid, which contains the Rous sarcoma virus LTR cloned upstream of the lacZ gene, and performed a P-galactosidase assay. The transfection efficiencies were very reproducible (less than 5% variation).
When the pLTRCAT plasmid (which contains the BLV LTR cloned upstream of the CAT gene) was transfected into D17 cells, no CAT activities were detected above background level, confirming that the BLV LTR is silent in uninfected cells (5, 24) . Cotransfection of plasmids pLTRCAT and pSGCREB was also not able to induce trans activation of the BLV LTR-directed CAT gene expression. In contrast, when a cAMP-dependent PK expression vector (pPKA, kindly provided by R. Maurer) was cotransfected with plasmids pLTRCAT and pSGCREB, detectable CAT activities were obtained (Table 1 ; net CAT activity = 742 cpm). These values represent 10% of the CAT activities obtained after cotransfection of plasmids pSGtax (which expresses a functional transactivator protein) and pLTRCAT (Table 1 ; net CAT activity = 7,257 cpm). Low, but detectable, levels of CAT activity were measured after cotransfection of plasmids pLTRCAT and pPKA (Table 1 ; net CAT activity = 131 cpm). These values represent only 1.8% of the CAT activity obtained after cotransfection of plasmids pSGtax and pLTR-CAT. Transfection of the pPKA plasmid into D17 cells induced a twofold increase of the basal PKA mean activity (470 instead of 255 pmol of peptide-incorporated phosphate per min as measured by the GIBCO PKA assay system). This corresponds in fact to a 200-fold increase of PKA activity assuming 1% transfection efficiency.
These experiments confirm that the tax protein is required to obtain efficient trans activation. They also demonstrate tax-induced trans activation inhibition of the BLV LTR may result from inefficient phosphorylation of the TBP (see Discussion). The CREB DNA-binding protein is phosphorylated at Ser-133 by the catalytic subunit of the cAMPdependent PKA (8) . Therefore, the cAMP-dependent PKA expression vector (pPKA) was cotransfected in D17 cells with plasmids pSGCREB, pSGtax, and the pLTRCAT reporter. A threefold increase in trans activation was observed ( (5), which contains the Rous sarcoma virus promoter (data not shown). Furthermore, the levels of tax protein remained fairly constant as revealed by radioimmunoprecipitation (data not shown).
These data demonstrate that the TBP is able to increase tax-induced trans activation in the BLV system. However, in similar conditions, the HTLV-I LTR was not responsive to the bovine TBP (data not shown). The reason for this is still unknown but could be due to specific differences between the bovine and human CREB proteins (26) or between the target sequences in their respective LTRs.
trans activation of BLV LTR in presence of PK inhibitors.
The BLV LTR is efficiently transactivated by CREB2 in the presence of PKA. We tested the effect of PK inhibitors ( Table  1) . The inhibitor H8 efficiently inhibits the activities of the cyclic nucleotide-dependent PKs. In fact, when pSGCREB and pPKA were cotransfected with the pLTRCAT reporter in the presence of 5 x i0' M H8, the basal trans activation of the BLV LTR was completely inhibited (Table 1 ; relative CAT activity of <1 cpm). The trans activation of the LTR by tax was also reduced (relative CAT activity of 54.2%) as well as the super-trans activation obtained after cotransfection of pSGtax, pSGCREB, and pPKA (relative CAT activity of 92.6%). The observed effect of the H8 compound was not due to a direct inhibition of the CAT enzyme since expression of the pRSVCAT vector (which contains the Rous sarcoma virus LTR cloned upstream of the CAT gene) was not affected (data not shown). Similar effects were also obtained with the PK inhibitor H7 (data not shown). (9) .
DISCUSSION
It is of particular interest that transcription regulation through the cAMP pathway can also be involved in the regulation of BLV viral information. After BLV infects its target cell and integrates into the host genome, the tax protein is probably not involved in the early steps of viral replication since no tax seems to be present (19) . More convincingly, when a plasmid containing an entire BLV provirus is transfected into mammalian cells, the viral LTR is activated even in the absence of the tax product (22 The expression of the BLV provirus in vivo thus seems not to be correlated with the total transcription level or the phosphorylation state of the TBP. Consequently, regulation of BLV expression in vivo seems to involve a very complex array of pathways in which CREB2 and/or other members of the CREB family and flanking sequences of the CRE target elements could play a major role (11, 21, 28) .
Phosphorylation of the CREB protein by the catalytic subunit of PKA is required to enhance tax-induced trans activation. In the absence of PKA, trans activation is inhibited by the CREB2 protein in the D17 cells. This suggests that the inhibition of trans activation by CREB2 results from the overexpression of an underphosphorylated form of the CREB protein that could titrate out essential cellular factors required for transcription. This mechanism may thus be considered as squelching.
Perhaps the most striking point of this report is that the BLV LTR (silent in uninfected cells) can be transactivated by CREB2 and PKA. The precise mechanism of this basal activation of LTR-directed gene expression is still unknown. In light of experiments performed in the tyrosine aminotransferase gene regulation system, we can hypothesize that the TBP/PKA pathway could relieve a cellular inhibition complex. The regulation of this gene is mediated through the CRE repressed by a tissue-specific extinguisher locus, Tse-I (2). Cotransfection of a vector expressing PKA allows us to overcome this inhibition. Boshart et al. (2) propose a model for the regulation of the limited onset of expression based on the antagonism between Tse-I and the cAMP pathway. A similar mechanism could well be involved in the BLV system. We can hypothesize that a cellular inhibitor is responsible for the lack of LTR-directed gene expression. The cAMP pathway and trans activation by tax (or another unknown mechanism) should compete with this inhibitor and subsequently allow the LTR-directed gene expression. Such a hypothesis is consistent with the observation that some BLV-infected cells (1 of 5,000) express viral information in vivo, suggesting that the inhibition is not absolute. The plasma protein identified by Gupta and Ferrer (10) which blocks BLV expression could act through cellular receptors and repress transcription via a similar mechanism.
In conclusion, CREB2 might be one of the key elements involved in BLV proviral regulation of expression, playing a role in derepression of proviral expression in the absence of tax and in regulation of tax-induced trans activation during the replicative cycle.
